The t(9;22)(q34;q11), generating the Philadelphia chromosome (Ph), is found in more than 90% of patients with chronic myeloid leukemia (CML) and in 15-30% of adults with acute lymphoblastic leukemia (ALL). Different groups have recently described the presence of large genomic deletions adjacent to the translocation breakpoint on the derivative chromosome 9 in 9-16% of CML patients. In the present paper, we report a FISH study of 45 Ph+ adult ALL patients with the aim of investigating the presence of deletions on derivative chromosome 9. In four (9%) of 45 cases, all showing an M-bcr, we detected deletions on der(9). The frequency of deletions we observed is similar to that reported in CML patients. The association of an M-bcr breakpoint and deletions appears significant (P ¼ 0.03). Some authors have suggested a very low incidence of der(9) deletions in ALL. This discrepancy can be explained by taking into account the low percentage of M-bcr ALL patients in the latter study (18%) compared to the present one (44%).
Introduction
The BCR-ABL fusion on the Philadelphia (Ph) chromosome is the hallmark of chronic myeloid leukemia (CML), detectable in about 95% of patients. 1 This rearrangement is also present in 15-30% of adults with acute lymphoblastic leukemia (ALL). 2 The Ph chromosome results from a reciprocal translocation between 9q34 and 22q11.2 that transposes the 3 0 segment of the ABL gene from 9q34 to the 5 0 of the BCR gene on 22q11. 3 The breakpoints within the ABL gene at 9q34 can occur in a large region at its 5 0 end, more frequently in the first intron. However, the splicing of the primary hybrid transcript produces an mRNA molecule in which the BCR sequences are always fused to ABL exon a2. In most CML patients and up to 50% of patients with Ph-positive ALL (Ph+ ALL), the BCR breakpoint occurs in a 5.8-kb area spanning exons 12-16 (originally referred to as exons b1-b5), defined as the major breakpoint cluster region (M-bcr). 4, 5 Owing to alternative splicing, fusion transcripts with either b2a2 or b3a2 junctions can be formed, giving rise to a 210-kDa chimeric protein (p210). In the remaining adult ALL patients and in rare cases of CML, the BCR break maps in the minor breakpoint cluster region (m-bcr), between the alternative exons e2' and e2. In these cases, a hybrid e1a2 transcript is produced and translated into a 190-kDa chimeric protein (p190). Moreover, a third breakpoint cluster region (m-bcr) was identified downstream of exon 19, giving rise to a 230-kDa fusion protein (p230). Some Ph + ALL and CML patients with p210-type transcripts also show expression of a p190-type fusion product because of alternative splicing of the primary mRNA. 6 Recent papers have pointed out the occurrence of 5 0 ABL and 3 0 BCR deletions next to the translocation breakpoint on the derivative chromosome 9 in a fair percentage of CML patients, ranging from 9 to 16%. [7] [8] [9] [10] The deletions are associated with a worse prognosis.
We report a detailed study of 45 Ph+ ALL cases performed to assess the incidence of der(9) deletions in these patients and to precisely characterize the extension of the deletions.
Materials and methods
A total of 45 newly diagnosed adult Ph + ALL patients were included in the study. The diagnosis of ALL was confirmed by cytologic evaluation on bone marrow and peripheral blood smears according to the French-American-British criteria. Among the 45 patients (20 females, 25 males; median age 48 years) considered in this study, there was no history of a prior myeloproliferative disorder; moreover, none of the patients considered in this study had clinical or hematological manifestations of CML during the course of disease. All patients were tested by conventional cytogenetic analysis, fluorescence in situ hybridization (FISH) and RT-PCR. FISH experiments were performed on bone marrow samples, analyzing a minimum of 25 metaphases for each probe. A mixture of PACs dJ835J22 and dJ1132H12 was used for the identification of the ABL gene. These two overlapping PACs encompass a region from about 40 kb upstream of exon 1b to 20 kb downstream of exon 11, completely including the ABL gene. 10 BACs bC72M14 and bA164N13 were used together to cover the whole BCR gene (Figure 1a ). In Ph + ALL cases, this probe combination results in a single red signal on normal chromosome 9, a single green signal on normal chromosome 22, and in the splitting of both ABL and BCR signals in the two derivative chromosomes. The colocalization of one red and one green signal on both der(9) and Ph chromosome, therefore, clearly identifies the two fusion genes on both derivative chromosomes (Figure 1b ). Patients not showing the expected hybridization pattern on the der(9) chromosome were interpreted as deleted cases (Figure 1c ). In order to precisely characterize the extension of the deletions, further FISH hybridizations were performed on the deleted cases with an appropriate set of BAC clones ( Figure 2 ) exactly positioned on the draft sequence of the human genome using the databases of Ensembl (http://www.ensembl.org/) and Santa Cruz University of California (http://genome.ucsc.edu/index.html). These databases were also queried for the identification of genes mapping inside the deleted regions.
Results
In all 45 patients, FISH analysis confirmed the presence of the classical t(9;22)(q34;q11) translocation initially diagnosed by conventional cytogenetics. Of these, 41 (91%) of the 45 analyzed cases displayed both red and green signals on der(9), while the remaining four (9%) cases showed the loss of both chromosome 9 and 22 sequences on the derivative chromosome 9.
In our series, 25 (56%) and 20 (44%) patients showed the mbcr and M-bcr rearrangement, respectively. Moreover, 8 M-bcr cases (40%) expressed both p210 and p190. All four patients with the der(9) deletion had the M-bcr breakpoint: the p210 transcript was detected in three patients and one showed both p210 and p190 forms (see Table 1 ). The association between the presence of deletions and the M-bcr breakpoint was found to be statistically significant (P ¼ 0.03).
FISH experiments indicated that the breakpoints location was heterogeneous ( Figure 2) . It was not possible to exactly define all breakpoints because in cases 1 and 3 the biological material was not sufficient to complete the analysis. The deletions of chromosome 22 sequences ranged from a few kilobases to 1 Mb. In patients 2 and 4, the BCR mixture gave a faint signal on der (9) , showing a small deletion of chromosome 22 sequences without involvement of any known gene. A region of chromosome 22 of about 1 Mb, downstream of the BCR gene, was lost in patients 1 and 3, revealing the deletion of 12 genes with known function. Among them, there are two TSGs: SMARCB1 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily b, member 1) and GSTT1 (glutathione S-transferase theta 1). The first gene encodes a member of the chromatin-remodeling SWI/SNF complexes. 11 The product of GSTT1 is a member of the theta class of glutathione Stransferases that catalyzes the conjugation of reduced glutathione to a variety of electrophilic and hydrophobic compounds. 12 The extension of chromosome 9 deletions ranged from 400 kb to 1.3 Mb. The 1.3 Mb interval includes eight genes with known function. Among them, three genes [PRDM12 (PR domain containing 12), FUBP3 (far upstream element, FUSE, binding protein 3), and ASS (argininosuccinate synthetase)] were absent in all patients with deletions. One tumor suppressor gene (TSG) called PTGES (prostaglandin E synthase) was lost in two cases (patients 1 and 2). PTGES encodes a microsomal glutathione Stransferase, which is a membrane protein. 13 
Discussion
In the present paper, we report a study on the occurrence of der(9)t(9;22) deletions in 45 adult Ph + ALL cases using appropriate BAC/PAC FISH probes. The molecular cytogenetic investigation detected the deletions in four cases. The frequency we observed (9%) is similar to that detected in CML patients in previous reports (9-16%). [7] [8] [9] [10] It is worth noting that all the deletions were found to be associated with the M-bcr (P ¼ 0.03). Reid et al 14 have suggested a significantly lower frequency of deletions in Ph + ALL patients in comparison to CML cases. Interestingly, the number of ALL cases showing M-bcr was significantly lower in the latter survey (18%) than in the present study (44%). If only patients with M-bcr are taken into account, the difference in terms of deletions between the ALL patients with deletions in the present study and the CML patients with deletions we have previously reported 10 is not significant (20 vs 14%; P ¼ NS).
The large deletion size variability we have detected matches previous reports on CML cases. [7] [8] [9] [10] The use of appropriate BAC/ PAC clones allowed us to precisely identify the genes lost as a consequence of the deletion. At least one TSG was lost in three patients with deletion on der (9) . It has recently been hypothesized that 'haplo-insufficiency' (absence of a single TSG allele), in contrast to Knudson's two-hit model, could provide, on its own, a selective advantage to an emerging tumor cell line and/ or increase the size of the target cell population for mutagenesis (including mutation or loss of the remaining TSG allele). 15 These data suggest that haplo-insufficiency for tumor suppression genes could play a role in ALL pathogenesis. However, in view of the small number of cases and the generally poor prognosis of adult Ph + ALL patients, 16 it is difficult to make hypotheses on the role of specific deleted genes. FISH results on der(9) chromosomes in the four Ph + ALL cases with deletions, using a panel of PAC/BAC probes (on the left) centromeric to ABL and telomeric to BCR. The breakpoint is represented by the horizontal line. Black boxes stand for absence of FISH signals, gray boxes for positive signals. White boxes indicate that FISH was not performed. The estimated size of the deletion is reported on the right, in correspondence to each breakpoint, and is expressed in megabases (Mb). The square brackets linking two probes indicate that they overlap. Note that most couples of probes encompassing the breakpoints are overlapping. In some instances the breakpoint was assumed to have occurred inside a specific probe since it consistently gave a fainter signal with respect to the signal on normal 9 or 22 chromosome. This result is indicated by the box being half-black and half-gray. Deletions on der(9) chromosome in adult Ph+ ALL G Specchia et al
